We Live in Time (2024) and Ovarian Cancer

The film assembles ten years of one relationship from fragments, deliberately out of sequence.

Almut is a German-born chef in London. She hits Tobias with her car after he steps into the road in a bathrobe, and the accident becomes a courtship.

The early scenes are already shadowed, because the film keeps cutting forward. Almut develops severe abdominal pain and is diagnosed with ovarian cancer. She is advised she can have a partial or a full hysterectomy. She chooses the partial operation, because she may want a child with him. She has one: their daughter Ella.

Three years later the pain returns. The cancer is back at stage 3. She is told she would need chemotherapy immediately, then surgery to remove the tumour, with no guarantee.

Against Tobias's wishes she trains in secret for the Bocuse d'Or, a culinary competition, and reaches the European final. She weakens during the last plating and her commis finishes the dish. Afterwards she goes ice skating with her family. The film implies her death and closes on Tobias teaching Ella to crack an egg.

This page describes the ending.

The most useful thing in this film is a conversation most cancer dramas skip entirely.

Ovarian cancer treatment can end fertility. Removing both ovaries and the uterus is the thorough option. Surgery that leaves one ovary in place is a genuine alternative for some people with early-stage disease, and pregnancy afterwards is possible.

That choice is real, and it is not automatic. It depends on the stage, on the type of tumour, and on what the person wants. The film shows it being offered and being weighed, which is exactly how the conversation should look.

If it may matter to you, raise it before surgery is planned rather than after.

The film's strongest scene is a bargaining conversation. Almut floats the idea of six to eight good months untreated instead of a longer stretch spent weakened by chemotherapy that may not work.

That is a fair rendering of a shared-decision conversation in advanced disease. The honest answer often involves months rather than cures, and the trade being weighed is quality of time against quantity of it.

Two things are worth naming. Nobody has to make that decision in one appointment. And choosing treatment does not lock you in; people change course when the trade changes.

Almut's fear is not mainly pain. It is that her daughter will remember only a dying woman, with no other version of her available.

That fear comes up constantly in real cancer care, and it drives decisions that look reckless from outside. Training in secret for a competition is not denial. It is an attempt to leave behind a different picture.

Tobias's helplessness rings true too, as do the ordinary logistics of school pickups that continue regardless. The film also refuses to give Almut a tidy deathbed speech, which is a kindness.

Almut stays articulate, physically strong and glamorous almost to the end, cooking at competition pace while under treatment for stage 3 disease.

Recurrent ovarian cancer rarely permits that. Fatigue is largely absent from the film. So is ascites, meaning fluid building up in the abdomen, which is common in advanced disease and can require repeated draining. So is bowel obstruction, and so are repeated admissions.

Her final decline is a fade rather than a process. Real deterioration is stepwise, and the steps are usually visible for weeks.

The route to Almut's first diagnosis is compressed to almost nothing, and so is everything between the two diagnoses.

In practice, the years between treatment and recurrence are not empty. They are built around clinic appointments, scans, and CA-125 blood tests used to monitor for return. Maintenance treatment may run for months after the main course.

That is worth knowing, because it is the part patients actually live in. It also explains a confusion the film invites: CA-125 is used to follow someone who already has a diagnosis. That is a different job from screening healthy people, where it has never been shown to work.

NCI notes ovarian cancer may cause no early symptoms, and that when symptoms appear the disease is often advanced. The signs are pain, swelling or pressure in the abdomen or pelvis, a sudden or frequent urge to urinate, trouble eating or feeling full quickly, a lump in the pelvic area, and gas, bloating or constipation.

Almut's severe abdominal pain is a dramatic entrance. The common version is duller: weeks of vague bloating and pelvic discomfort blamed on food, stress or hormones.

The rule that separates the two is not the symptom, it is the pattern. New. Persistent. There most days for several weeks. That combination deserves an appointment, and it should not be written off as irritable bowel syndrome or perimenopause.

In February 2018 the US Preventive Services Task Force gave ovarian cancer screening a grade D. It recommends against screening women who have no symptoms and no known high-risk hereditary syndrome.

NCI reports that pelvic exams, transvaginal ultrasound and the CA-125 blood test have not been shown to reduce deaths from ovarian cancer, alone or in combination.

The harms are concrete. A false positive usually leads to more tests and procedures, which NCI notes carry risks including infection, blood loss, bowel injury, and heart and blood vessel problems. It can also lead to an unnecessary operation to remove an ovary.

People with a strong family history, or a known BRCA1 or BRCA2 change, are a separate case and should be referred for genetic counselling.

Cancer Explained is free and ad-free. Nothing is sold on this page. No sponsor sits behind it.

Did this page help you understand something about We Live in Time, or nudge you toward a question you had been avoiding? Reader support is what keeps this page on We Live in Time free, along with every other page here. Support our work.

We Live in Time is honest about the questions and dishonest about the body. The fertility conversation, the trade between time and treatment, and the fear of being remembered only as a patient are all real. The glossy competence is not.

If you have been bloated, full quickly, or uncomfortable in the pelvis most days for several weeks, that is the sentence to take from this page. Ask for it to be looked into.

Most of the time it will be something else. We Live in Time cannot tell you what to watch for, but screening and possible warning signs can.

• NCI — Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer Treatment (PDQ®), Patient Version
• NCI — Ovarian, Fallopian Tube, and Primary Peritoneal Cancers Screening (PDQ®), Patient Version
• US Preventive Services Task Force — Ovarian Cancer: Screening (2018)

This page discusses We Live in Time for education. It is not medical advice, and nothing here is a judgement of anyone's real medical care. Spotted an error? Please email [email protected].